OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
54
Views
13
CrossRef citations to date
0
Altmetric
Original Research
NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy
Boksoon Chang1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of Medicine
, Myung Jae Park1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of Medicine
, Sue In Choi2 Division of Respiratory and Critical Care Medicine, Department of Internal Medicine
, Kwang Ho In2 Division of Respiratory and Critical Care Medicine, Department of Internal Medicine
, Chul Hwan Kim3 Department of Pathology, College of Medicine, Korea University, Seoul, South Korea
& Seung Hyeun Lee1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of MedicineCorrespondence[email protected]
Pages 4625-4633
|
Published online: 19 Sep 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.